Depression Clinical Trials in San Francisco, CA

57 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501	Phase 3	Neumora Therapeutics, Inc.	<1 mi
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations	N/A	Stanford University	<1 mi
Biomarkers of Depression and Treatment Response	N/A	University of California, San Francisco	<1 mi
Probiotic Administration for Adolescent Depression	Early 1	University of California, San Francisco	<1 mi
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy	—	NeurOptics Inc	<1 mi
Reward Processing and Depressive Subtypes: Identifying Neural Biotypes	—	San Francisco Veterans Affairs Medical Center	<1 mi
Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression	N/A	Andrew Krystal	<1 mi
Near Infrared Spectroscopy (NIRS) for Assessment of Depression	N/A	University of California, San Francisco	<1 mi
Model-based Electrical Brain Stimulation	N/A	University of Southern California	<1 mi
Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression	N/A	San Francisco Veterans Affairs Medical Center	<1 mi
Closed-Loop Deep Brain Stimulation for Major Depression	N/A	Andrew Krystal	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Treating Major Depression With Yoga Mono-therapy	N/A	University of California, San Francisco	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV	Phase 2	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Building Resilience for Surgical Recovery	N/A	The University of Texas Health Science Center, Houston	<1 mi
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project	—	University of Southern California	<1 mi
SUpport From PEeRs to Expand Access Study - Community	N/A	University of California, Berkeley	<1 mi
Psilocybin Therapy for Depression in Parkinson's Disease	Phase 2	Joshua Woolley, MD, PhD	<1 mi
Ketamine for Veterans With Parkinson's Disease	Phase 2	VA Office of Research and Development	<1 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	8 mi
Kintsugi Voice Device Pivotal Study	—	Kintsugi Mindful Wellness, Inc.	10 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	14 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	18 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	18 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	21 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	21 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder	Phase 2	Janssen Research & Development, LLC	21 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	21 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	21 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	21 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	21 mi
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)	—	Janssen Research & Development, LLC	21 mi
rTMS for Military TBI-related Depression	N/A	Henry M. Jackson Foundation for the Advancement of Military Medicine	28 mi
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder	N/A	Stanford University	28 mi
Stratified Pharmacological Approaches for Regulating Circuit-Level Effects	Phase 2	Stanford University	28 mi
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression	Phase 2	Stanford University	28 mi
Sleep Mechanisms Of Regulating Emotions	N/A	Stanford University	28 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	28 mi
Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans	N/A	Stanford University	28 mi
fMRI Neurofeedback With Matter Neuroscience App	N/A	Stanford University	28 mi
Optimizing Brain Excitability in Depression	N/A	Stanford University	28 mi
RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS	N/A	University of Minnesota	28 mi
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression	N/A	Stanford University	28 mi
Biomarker-guided rTMS for Treatment Resistant Depression	Phase 3	Weill Medical College of Cornell University	28 mi
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia	N/A	Stanford University	28 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	28 mi
The BEAR Program for Women With Trauma Who Have Suicidal Thoughts	N/A	Stanford University	28 mi
Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements	—	Kernel	35 mi
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness	Phase 2	Brigham and Women's Hospital	35 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	42 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	42 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	42 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	42 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.